International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19

Publication date

2020-09

Authors

Börger, Verena
Weiss, Daniel J.
Anderson, Johnathon D.
Borràs, Francesc E.
Bussolati, Benedetta
Carter, David R.F.
Dominici, Massimo
Falcón-Pérez, Juan M.
Gimona, Mario
Hill, Andrew F.

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc_nd

Abstract

STATEMENT: The International Society for Cellular and Gene Therapies (ISCT) and the International Society for Extracellular Vesicles (ISEV) recognize the potential of extracellular vesicles (EVs, including exosomes) from mesenchymal stromal cells (MSCs) and possibly other cell sources as treatments for COVID-19. Research and trials in this area are encouraged. However, ISEV and ISCT do not currently endorse the use of EVs or exosomes for any purpose in COVID-19, including but not limited to reducing cytokine storm, exerting regenerative effects or delivering drugs, pending the generation of appropriate manufacturing and quality control provisions, pre-clinical safety and efficacy data, rational clinical trial design and proper regulatory oversight.

Keywords

Immunology and Allergy, Immunology, Oncology, Genetics(clinical), Cell Biology, Transplantation, Cancer Research

Citation

Börger, V, Weiss, D J, Anderson, J D, Borràs, F E, Bussolati, B, Carter, D R F, Dominici, M, Falcón-Pérez, J M, Gimona, M, Hill, A F, Hoffman, A M, de Kleijn, D, Levine, B L, Lim, R, Lötvall, J, Mitsialis, S A, Monguió-Tortajada, M, Muraca, M, Nieuwland, R, Nowocin, A, O'Driscoll, L, Ortiz, L A, Phinney, D G, Reischl, I, Rohde, E, Sanzenbacher, R, Théry, C, Toh, W S, Witwer, K W, Lim, S K & Giebel, B 2020, 'International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells : considerations for potential therapeutic agents to suppress coronavirus disease-19', Cytotherapy, vol. 22, no. 9, pp. 482-485. https://doi.org/10.1016/j.jcyt.2020.05.002